You are here: Industry Insights > lung cancer

News List

Access to High-Cost Targeted Treatments Varies for Lung Cancer drugs
December 26, 2019
Not all patients have access to new, high-cost lung cancer drugs, according to a study recently published in the Journal of the National Cancer Institute.
One-Third of Lung Cancer Patients Battle Depression: Study drugs
December 25, 2019
Depression is common among lung cancer patients and can damage their quality of life and treatment outcomes, a new study indicates.The findings suggest that doctors should screen lung cancer patients for depression and refer them for mental health care if
Many Lung Cancer Patients Receive Meds That Prolong QTc Interval drugs
December 17, 2019
A considerable proportion of patients with lung cancer are prescribed medications that prolong the corrected QT (QTc) interval ...
AstraZeneca’s Stage IV Lung Cancer Drug Misses Primary Endpoint americanpharmaceuticalreview
August 23, 2019
AstraZeneca has announced final overall survival (OS) results from the Phase III NEPTUNE trial, a randomized, open-label, multi-center, global trial of Imfinzi (durvalumab) in combination with tremelimumab ...
AstraZeneca’s Tagrisso helps lung cancer patients live longer: study expresspharma
August 12, 2019
AstraZeneca reported that a late-stage study showed its top-selling drug, Tagrisso, had significantly helped patients with a type of lung cancer live longer without the disease worsening.
Can BMS parlay its surprise 'win and a miss' in first-line lung cancer into a net gain? fiercepharma
July 28, 2019
If you thought you knew what was coming in Bristol-Myers Squibb’s CheckMate-227 trial, forget it.
VolitionRx commences lung cancer clinical study with Fosun in China biospectrumasia
July 22, 2019
Belgium based VolitionRx Limited has executed a contract under the previously announced Memorandum of Understanding, with Shanghai Fosun Long March Medical Science Co., Ltd. to help introduce the Nu.Q(TM) platform to China.
LCRF Awards $300,000 in Research Grants americanpharmaceuticalreview
June 13, 2019
The Lung Cancer Research Foundation (LCRF) announced the awardees of the 2019 LCRF Research Grant on Disparities in Lung Cancer.
AI could spot lung cancer before radiologists pharmatimes
May 21, 2019
Artificial Intelligence (AI) ‘deep learning’ has been found to detect malignant lung nodules on low-dose chest computed tomography (LDCT) scans sooner than radiologists.
AstraZeneca tees up PGA champ Day to push biomarker testing in lung cancer fiercepharma
May 09, 2019
AstraZeneca and pro golfer Jason Day are on a mission to encourage biomarker testing for lung cancer. For Day, the awareness campaign is personal—he found out two years ago that his mother had stage IV lung cancer.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 14 15 Next page